ADVERTISEMENT

Shilpa Medicare Q1 Review - Weak Quarter; Import Alert Remains An Overhang: ICICI Securities

Shilpa Medicare Q1 Review - Weak Quarter; Import Alert Remains An Overhang: ICICI Securities

<div class="paragraphs"><p>An employee inspects a tray of&nbsp; tablets inside  pharmaceutical laboratories. (Photographer: Martin Leissl/Bloomberg).</p></div>
An employee inspects a tray of  tablets inside pharmaceutical laboratories. (Photographer: Martin Leissl/Bloomberg).
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More